News Feed
XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
● Compositions and Methods for Enhancing Anti-viral Therapies ●
[…]
Year: 2021
News Feed
Sigyn Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome (the Cytokine Storm), today […]
News Feed
XORTX Confirms $1 Million in Warrant Exercise Proceeds
CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to […]
Spotlight
Citius Pharmaceuticals (NASDAQ: CTXR)
Myron Holubiak, CEO of Citius Pharmaceuticals took time to update WSA’s listeners on the companies’ progress since their previous interview. Mr. Holubiak provided an overview of the progress on the CTXR’s main products Mino-Lok and Mino-Wrap and shared how they are adapting the product to deal with COVID compliance and restrictions. He also talked about other programs in early stage development and went over key factors that make Citius a unique investment opportunity. Have a look below: […]
News Feed
Green Star Products: Ready to Close COVID-19 Contract at Shareholders Meeting
SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) — Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the COVID-19 contract with BTR […]
News Feed
ARCPACIFIC RESOURCES OUTLINES THREE MAIN SILVER COPPER AND GOLD ZONES ON LMSL PROJECT
Identified multiple hydrothermal system centers in and surrounding the Project area, representing a possible “cluster” scenario. […]
News Feed
Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
Completion of research and development phase for HaluGen’s Psychedelics Genetic Test […]
Featured Interviews
Entheon Biomedical Corp. (CSE: ENBI)
Interview with Timothy Ko, CEO […]
News Feed
Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
Science in Action confirmed that they have received ethics approval for an in-vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT). […]
News Feed
ArcPacific Resources Announces AGSM Results
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]